Filtros de búsqueda

Lista de obras de

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

scientific article published on 19 March 2019

Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer

artículo científico publicado en 2016

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

artículo científico publicado en 2014

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger

artículo científico publicado en 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

artículo científico publicado en 2016

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study.

artículo científico publicado en 2016

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

artículo científico publicado en 2020

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

artículo científico publicado en 2015

Integrating mHealth in Oncology: Experience in the Province of Trento

artículo científico publicado en 2015

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2017

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2015

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

artículo científico publicado en 2015

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

artículo científico publicado en 2016

The prognostic value of pain in castration-sensitive prostate cancer

artículo científico publicado en 2020

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda